ARS Investment Partners, LLC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 733020 New York, NY

Position in HRMY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$622,064

+$112,142 QoQ

Shares Held

17,085

-6.2% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

of 19 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

ARS Investment Partners, LLC holds $105,565,453 across 4 Biotechnology names. HRMY ranks #4 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	210,462	$56,134,424
2	REGN	Regeneron Pharmaceuticals, Inc.	45,484	$28,361,093
3	BHVN	Biohaven Ltd.	1,374,185	$20,447,872
4	HRMY	Harmony Biosciences Holdings, Inc. This page	17,085	$622,064

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$622,064	17,085	-6.2%	Shares	Sole	2026-07-09
2026-03-31	$509,922	18,205	-14.1%	Shares	Sole	2026-04-16
2025-12-31	$793,491	21,205	-1.2%	Shares	Sole	2026-02-05
2025-09-30	$591,299	21,455	-11.5%	Shares	Sole	2025-10-15
2025-06-30	$766,458	24,255	-0.8%	Shares	Sole	2025-08-11
2025-03-31	$811,163	24,440	0.0%	Shares	Sole	2025-05-14
2024-12-31	$840,980	24,440	—	Shares	Sole	2025-01-16
No filing history on record for this holder in this stock.